(Q42981929)

12 November 2017

title

Risk factors and the effect of interferon therapy in the development of hepatocellular carcinoma: a multivariate analysis in 343 patients (English)

1 reference

12 November 2017

main subject

multivariate statistics

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

Kuwana K

1

1 reference

12 November 2017

Ichida T

2

1 reference

12 November 2017

Kamimura T

3

1 reference

12 November 2017

Ohkoshi S

4

1 reference

12 November 2017

Ogata N

5

1 reference

12 November 2017

Harada T

6

1 reference

12 November 2017

Endoh K

7

1 reference

12 November 2017

Asakura H

8

1 reference

12 November 2017

publication date

1 February 1997

1 reference

Journal of Gastroenterology and Hepatology

12 November 2017

published in

1 reference

12 November 2017

volume

12

1 reference

12 November 2017

issue

2

1 reference

12 November 2017

page(s)

149-155

1 reference

Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00398.X

Clinical backgrounds of the patients having different types of hepatitis C virus genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00398.X

Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00398.X

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00398.X

Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00398.X

Hepatitis C virus genotypes are not responsible for development of serious liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00398.X

Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00398.X

Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00398.X

Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00398.X

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00398.X

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00398.X

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00398.X

A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00398.X

Hepatitis C virus genotypes and development of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00398.X

Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00398.X

A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00398.X

Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00398.X

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00398.X

Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00398.X

10.1111/J.1440-1746.1997.TB00398.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference